Role of hypoxia in the activation of innate immunity and in the progression of chronic kidney disease associated with the renal ablation model of 5/6

Hypoxia is thought to influence the pathogenesis of chronic kidney disease (CKD), but direct evidence that prolonged exposure to tissue hypoxia initiates or aggravates CKD is lacking. We tested this hypothesis by chronically exposing normal rats and rats with 5/6 nephrectomy (Nx) to hypoxia. In addition, we investigated whether such effect of hypoxia would involve activation of innate immunity. Adult male Munich-Wistar rats underwent Nx (n=54) or sham surgery (sham, n=52). Twenty six sham (S+nor) and 26 Nx (Nx+nor) rats remained in normoxia, while 26 sham rats (S+hyp) and 28 Nx rats (Nx+hyp) were kept in a normobaric hypoxia chamber (12% O2) for 8 weeks. Hypoxia was confirmed by immunohistochemistry for Pimonidazole (Hypoxyprobe®). Hypoxia was confined to the medullar area in S+nor and spread to the cortical area in S+hyp. Exposure to hypoxia promoted no renal injury or elevation of the content of IL1beta or TLR-4 in Sham. In Nx, hypoxia extended to the cortical area, a process that was intensified in Nx+hyp but, unexpectedly, attenuated hypertension, inflammation, innate immunity activation, renal injury and oxidative stress. The present study, in disagreement with current concepts, shows evidence that hypoxia exerts a renoprotective effect in the Nx model, instead of acting as a factor of renal injury. The mechanisms for this unexpected beneficial effect are unclear, and may involve NF-kB inhibition, amelioration of oxidative stress and limitation of angiotensine II production by the renal tissue (AU)